Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 17, 2016
- Accepted in final form January 24, 2017
- First Published February 24, 2017.
Author Disclosures
- Yasuo Harigaya, MD, PhD,
- Takashi Matsukawa, MD, PhD,
- Yukio Fujita, MD, PhD,
- Kazuyuki Mizushima, MD, PhD,
- Hiroyuki Ishiura, MD, PhD,
- Jun Mitsui, MD, PhD,
- Shinichi Morishita, MD, PhD,
- Mikio Shoji, MD, PhD,
- Yoshio Ikeda, MD, PhD and
- Shoji Tsuji, MD, PhD
- Yasuo Harigaya, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Takashi Matsukawa, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) GlaxoSmithKline
(1) JSPS KAKENHI, 15H06160, Lead investigator, 2015-2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yukio Fujita, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kazuyuki Mizushima, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hiroyuki Ishiura, MD, PhD,
NONE
NONE
A speaker honoraria from Sanofi and Sumitomo Dainippon Pharma.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Funds from the the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists (Start-up) 24890044, 2012-2014 and Grant-in-Aid for Young Scientists (B) 15K20941, 2015-2017).A fund from the Ministry of Health Labour and Welfare (H23-Jitsuyoka (Nambyo)-ippan-010, 2013).A fund from Japan Agency for Medical Research and Development.(2015-2016)
NONE
A fund from the Cell Science Research Foundation, 2013
NONE
NONE
NONE
NONE
NONE
NONE
- Jun Mitsui, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received (1) a fund from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research (C) 15K09334), 2015-2017.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shinichi Morishita, MD, PhD,
NONE
NONE
NONE
Journal of BMC GenomicsJournal of Bioinformatics and Computational Biology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mikio Shoji, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yoshio Ikeda, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Grants-in-Aid for Scientific Research (C) (16K09665, 2016-2017) from the Ministry of Education, Culture, Sports, Science and Technology, Japan Grants-in-Aid from the Research Committee for Ataxic Disease (Mizusawa H, 2015-2017), the Ministry of Health, Labour and Welfare, Japan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shoji Tsuji, MD, PhD
NONE
NONE
Commercial entity, speaker honorariaKyowa Pharmaceutical Co. Ltd.Dainippon Sumitomo Pharma Co. Ltd.FP-Pharmaceutical Co.Eisai Co. Ltd.Genzyme Japan K.K.Convention LinkageNippon ZokiSanofiBoehringer IngelheimMitsubishi Tanabe Pharma Co.Fukuda Ad AgencyActelion Pharmaceuticals Japan Ltd.
Neurology and Clinical NeuroscienceRole: Editor-in-Chief
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Ministry of Education, Culture, Sports, Science andTechnology of Japan (KAKENHI (22129001,22129002 and 26253054)]), and the Japan Agency for MedicalResearch and Development (Grant-in-Aid [H26-NanchiseishikkanJitsuyoka-Ippan-080, 26310101, and Ninchisho Kenkyu26340101]).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (Y.H., K.M.), Maebashi Red Cross Hospital; Department of Neurology (T.M., H.I., J.M., S.T.), Graduate School of Medicine, Tokyo University; Department of Neurology (Y.F., Y.I.), Gunma University Graduate School of Medicine, Maebashi; Department of Computational Biology and Medical Sciences (S.M.), Graduate School of Frontier Sciences, Tokyo University, Chiba; and Department of Neurology (M.S.), Hirosaki University Graduate School of Medicine, Japan.
- Correspondence to Dr. Harigaya: y-harigaya{at}maebashi.jrc.or.jp
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.